AXL was identified as one of the most highly expressed genes following DV treatment (18-fold induction) and was of particular importance as it is implicated in many cancers [51, 52] A number of its oncogenic properties include a role in cell proliferation, survival and inhibition of apoptosis [53, 54]. The gene discussed is AXL; the disease is cancer.